Abu Dhabi's biggest sovereign fund is in talks with U.S. firm KKR to invest in Telecom Italia's (TIM) last-mile network in a deal that has drawn scrutiny from Italy's government, three sources close to the matter told Reuters. The government has special vetting powers to block unwanted bids in industries deemed of strategic importance. TIM agreed in August to sell KKR a 37.5% stake of a newly created company, FiberCop, into which it has transferred its 'last-mile' network connecting street cabinets to people's homes.
Moderna Inc said it will apply for U.S. and European emergency authorization of its COVID-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns. The filing sets Moderna's product up to be the second vaccine likely to receive U.S. emergency use authorization this year.
LONDON, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Midpoint Holdings Ltd. (TSXV: MPT) (“Midpoint” or the “Company”) is pleased to announce it has launched Virtual International Bank Account Numbers (“Virtual IBANs”). Clients can now open business Virtual IBAN accounts as well as personal Virtual IBAN accounts online with Midpoint in 15 minutes. The Company plans to enable the Virtual IBANs for all its existing clients for free, and at writing, Midpoint currently serves more than 3,000 clients from over 50 countries.“The main advantage is that businesses as well as individuals can have a number of Virtual IBANs and have the payments that are made to them rerouted to the same master account. This mimics the effect of having multiple bank accounts, without the banking fee expenses and the hassle to maintain them,” said Hertz Zhang, Operations Director.Virtual IBANs can be generated quickly and in bulk. “Law firms can offer unique escrow ‘named accounts’ (that are distinct Virtual IBANs) for each of their clients. This would reduce costs and streamline the closing mechanics of private placements or other escrow transactions. Landlords can offer each of their tenants a distinct Virtual IBAN for their rent payment wire instructions, education establishments can offer each student a named account for tuition fees, and businesses such as suppliers can offer unique Virtual IBAN accounts to each of their customers,” said David Wong, CEO of Midpoint. “It is similar to having all the benefits of segregated accounts with the same flexibility of a pooled or omnibus account—best of both worlds,” he added.“With end-to-end transparency and segregation of funds, Virtual IBANs help businesses to comply with AML (Anti-Money Laundering) and KYC (Know Your Customer) rules,” Zhang added.Virtual IBANs cut through the bureaucracy involved with setting up an account at a traditional banking establishment. As many businesses making foreign payments know, setting up any payment account can be a convoluted and lengthy process. That is not the case with a virtual IBAN from an online platform. For instance, with a Virtual IBAN, there is no requirement for a person to reside in or a business to be registered in the same country as the Virtual IBAN accounts.The Company is currently working towards offering USD local accounts and Euro virtual accounts.About MidpointHeadquartered in London, UK, Midpoint is an FCA authorized payments institutions specializing in cross-border payments and foreign exchange. SMEs, overseas professionals, property owners, foreign students, individuals, and anyone involved in international payments use Midpoint for transparent, multi-party, multi-currency services. Midpoint currently handles transactions in 24 currencies with the ability to collect and transfer across over 200 countries. This highly secure platform provides customers with the most cost-effective FX at the midpoint of the interbank buy/sell rate, therefore removing the spread as well as hidden costs and fees. Midpoint Holdings Limited is listed on the TSX Venture Exchange and cross-listed on the Frankfurt Stock Exchange. For information on Midpoint, please visit: https://www.midpoint.com.For further information please contact:Corbin Comishin, CFODavid Wong, Chairman and CEO Midpoint Holdings Limited,22-25 Portman Close, Marylebone, 505 Kootenay Street, Nelson,London W1H 6BS, United Kingdom British Columbia V1L 1K9, CanadaTel: 0044 20 7448 3082 Tel: 001 250 352 7667Email: email@example.com Neither the TSX Venture Exchange (the “TSXV”) nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release and has neither approved nor disapproved of the contents of this news release.Forward-looking informationThis news release contains certain “forward-looking information” within the meaning of applicable securities law. Forward looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “would”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Forward-looking information is based on the opinions and estimates of management at the date the information is provided, and is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. For a description of the risks and uncertainties facing Midpoint and its business and affairs, readers should refer to Midpoint’s Management’s Discussion and Analysis. Midpoint undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change, unless required by law. The reader is cautioned not to place undue reliance on forward-looking information.Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.
Summary “North America Electrophysiology Procedures Outlook to 2025” is a comprehensive databook report, covering key procedures data on the North America Electrophysiology Procedures.New York, Nov. 30, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Electrophysiology Procedures Outlook to 2025 - Electrophysiology Diagnostic Catheters Procedures and Electrophysiology Ablation Catheters Procedures" - https://www.reportlinker.com/p05993104/?utm_source=GNW The databook report provides procedure volumes within segments - Electrophysiology Diagnostic Catheters Procedures and Electrophysiology Ablation Catheters Procedures. The North America Electrophysiology Procedures report provides key information and data on - \- Procedure volume data for Electrophysiology Procedures related to the country. Data is provided from 2015 to 2025. Scope North America Electrophysiology Procedures is segmented as follows - \- Electrophysiology Diagnostic Catheters Procedures \- Electrophysiology Ablation Catheters Procedures Reasons to Buy The North America Electrophysiology Procedures report helps you to develop - \- Business strategies by identifying the key segments poised for strong growth in the future. \- Market-entry and market expansion strategies. \- Develop investment strategies by identifying the key segments expected to register strong growth in the near future. Read the full report: https://www.reportlinker.com/p05993104/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ CONTACT: Clare: firstname.lastname@example.org US: (339)-368-6001 Intl: +1 339-368-6001
The Snus Market will grow by $ 780 million during 2020-2024
French champion believes Groupama-FDJ can target sprints and GC in July
SCOTTSDALE, Ariz., Nov. 30, 2020 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of chiropractic clinics, announced that management is scheduled to participate in the Roth Virtual Deer Valley Conference, December 10 – 11, 2020. President and CEO Peter D. Holt and CFO Jake Singleton will host one-on-one meetings on Thursday, December 10th and Friday, December 11th. Interested investors should contact their Roth representative.About The Joint Corp. (NASDAQ: JYNT) The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, the company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With more than 550 locations nationwide and over seven million patient visits annually, The Joint is a key leader in the chiropractic industry. Named on Franchise Times “Top 200+ Franchises” and Entrepreneur’s “Franchise 500®” lists, The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.Business Structure The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Washington, West Virginia and Wyoming, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.Media Contact: Margie Wojciechowski, The Joint Corp., email@example.com Investor Contact: Kirsten Chapman, LHA Investor Relations, 415-433-3777, firstname.lastname@example.org
Spotlight Therapeutics, Inc., a biotechnology company developing non-viral gene editing therapeutics for direct in vivo editing of target genes, closed its Series A financing bringing the total raised to $30 million. The financing was led by GV, formerly Google Ventures, with participation from additional undisclosed investors.
Save on Theragun & Hypervolt deals at the Cyber Monday sale, including all the top massage gun offers
TROY, Mich., Nov. 30, 2020 (GLOBE NEWSWIRE) -- Altair (NASDAQ: ALTR), a global technology company providing software and cloud solutions in the areas of simulation, data analytics, and high-performance computing, announced today that James Scapa, chairman and chief executive officer, and Howard Morof, chief financial officer, will present at the Berenberg European Conference on Tuesday, December 1, 2020 at 11:00 a.m. ET. A live webcast, as well as a replay, of the presentation will be available on the company’s investor relations website at http://investor.altair.com.About Altair Altair is a global technology company that provides software and cloud solutions in the areas of simulation, data analytics, and high-performance computing. Altair enables organizations across broad industry segments to compete more effectively in a connected world while creating a more sustainable future. To learn more, please visit www.altair.com.Media Relations Jennifer Ristic Altair 216-849-3109 email@example.comInvestor Relations The Blueshirt Group Monica Gould 212-871-3927 firstname.lastname@example.org
Cyber Monday headphones deals have arrived, find the best Cyber Monday Bluetooth & wireless headphones deals belowCyber Monday experts have listed all the top headphones deals for Cyber Monday 2020, including offers on Sony, Bose, Beats & more headphones. Links to the latest deals are listed below.Best Headphones Deals: * Save up to 77% on wireless headphones from top brands like Bose, JBL & Beats by Dre at Walmart \- save on a wide range of top-rated wireless Bluetooth headphones and noise cancelling headphones * Save up to 60% on top-rated headphones from JBL, Bose, Logitech & more top brands at Dell.com \- get the latest deals on headphones from Bose, Samsung, Logitech, VisionTek & more * Save up to 56% on headphones from Sony, Apple, Bose, Anker & more top brands at Amazon \- check the latest deals on a wide range of best-selling wireless headphones and earbuds * Save up to $40 off on Samsung Galaxy Buds earbuds at Dell.com * Save up to 50% off on premium Sennheiser headphones & earbuds at Sennheiser.com \- check out the latest deals on wireless headphones, noise cancelling headphones, Bluetooth headphones, wireless earbuds, and more * Save up to 60% on JBL headphones & wireless earbuds at JBL.com * Save up to 43% on Bose noise canceling headphones & earbuds at Bose.com \- get the latest deals on best-selling Bose headphones & earbuds * Save up to 50% on a wide range of headphones at Verizon.com \- check the latest deals on wireless, Bluetooth, and noise cancelling headphones * Save up to 40% on the latest Beats by Dre wireless headphones & Bluetooth speakers at Amazon \- check the latest deals on top-rated Beats headphones and speakers like the Powerbeats Pro, Solo 3, and Beats Pill speaker * Save up to 43% on Bose wireless & noise canceling headphones at Walmart \- check the latest deals on Bose 700, QuietComfort 35 (QC35), and SoundSport Free True wireless earbuds * Save up to $50 on Apple AirPods & AirPods Pro at Amazon \- check live prices on the latest AirPods (2nd Generation) with Wireless Charging Case * Save on Apple AirPods at Verizon.com * Save up to 50% on Sennheiser headphones at Amazon \- check live prices on top-rated Sennheiser HD and Sennheiser Consumer Audio headphones * Save up to 50% on Jaybird wireless headphones & earbuds at Amazon \- check live prices on the best-selling Jaybird Run, Freedom, X2 Sport, Vista, and more * Save up to $150 on Bose, Beats, Sony, and more top-rated noise-canceling headphones at Walmart \- click the link for the latest prices on a wide range of best-selling Bluetooth noise-canceling headphones * Save up to 40% off on noise cancelling headphones from Logitech, Bose, Sony, & Sennheiser at Dell.com \- click the link for live prices on top-rated noise cancelling headphone models * Save up to 56% on top-rated noise-canceling headphones at Amazon \- check live prices on Sony WH-1000XM3s, Bose QC35 II, Sennheiser, Shure, and more wireless noise-canceling headphones * Save up to 33% off on wireless earbuds from Samsung Galaxy Buds, Bose, JBL, Jabra & more at Dell.com \- click the link to see live prices on the Jabra Elite 65t, Samsung Galaxy Buds+, Skullcandy Sesh, and more * Save up to 75% on Jabra Elite, Samsung Earbuds, Apple, and more wireless earbuds at Walmart \- click the link for live prices on a wide range of true wireless earbuds from brands like Apple, Beats, Bose, and more * Save up to 60% on top-rated wireless earbuds at Amazon \- check live prices on the Jabra Elite, Samsung Galaxy Buds, Apple earbuds Beats Powerbeats Pro, Bose, and more true wireless earbuds brands * Save up to 68% on Sony noise canceling headphones & wireless earbuds at Walmart \- check the latest deals on best-selling Sony noise cancelling earbuds & headphones like the WF-1000XM & WH1000XM series * Save on a wide range of Sony headphones and earbuds at Dell.com \- check live prices on the Sony WH-1000XM4, WH-XB900N, WF-XB700, WF-1000XM3, and more * Save up to 46% on Sony headphones such as the Sony WH-1000XM3 & WH-1000XM4 at AmazonInterested in more deals? Check out Walmart’s Cyber Monday sale and Amazon’s Cyber Monday sale to compare thousands more active offers. Consumer Articles earns commissions from purchases made using the links provided.About Consumer Articles: Consumer Articles shares informative e-commerce news. As an Amazon Associate and affiliate Consumer Articles earns from qualifying purchases.Contact: Andy Mathews (email@example.com)
~ Strong Presence at ASH Featuring Five Presentations, Including Late-Breaking Oral Presentation on HOPE-B Pivotal Trial ~~ uniQure to Host Investor Webcast Tuesday, December 8, 2020 at 5:00 p.m. ET ~LEXINGTON, Mass. and AMSTERDAM, Nov. 30, 2020 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that Steven Pipe, M.D., professor of pediatrics and pathology and pediatric medical director of the hemophilia and coagulation disorders program at the University of Michigan, will present clinical data from the HOPE-B pivotal trial of etranacogene dezaparvovec in hemophilia B at the virtual 62nd American Society of Hematology (ASH) Annual Meeting. * Dr. Pipe, principal investigator of the HOPE-B pivotal trial, will participate in the ASH press briefing scheduled for Monday, December 7 from 10:30 a.m. – 11 a.m. E.T. * Dr. Pipe will present a late-breaking oral presentation on the HOPE-B data on Tuesday, December 8 at 11:45 a.m. E.T.uniQure management along with Dr. Pipe will host an investor webcast on Tuesday, December 8, 2020, at 5:00 p.m. ET. To access the live webcast with presentation slides, please visit the Investor Relations section of uniQure’s website at www.uniQure.com. The webcast will be archived for 90 days. The event also may be accessed by dialing (877) 870 – 9135 for domestic callers and +44 020 719 283 38 for international callers. The passcode is 3164585. Please specify to the operator that you would like to join the “uniQure Conference Call.”Late-Breaking Oral Presentation Title:First Data from the Phase 3 HOPE-B Gene Therapy Trial: Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua hFIX variant; AMT-061) in Adults with Severe or Moderate-Severe Hemophilia B Treated Irrespective of Pre-Existing Anti-Capsid Neutralizing Antibodies Presenter:Steven Pipe, M.D. Session Name:Late-Breaking Abstracts, LBA-6 Date:Tuesday, December 8, 2020 Presentation Time:11:45 a.m. ET (8:45 a.m. PT) Oral Presentation Title:Etranacogene Dezaparvovec (AAV5-Padua hFIX variant), an Enhanced Vector for Gene Transfer in Adults with Severe or Moderate-Severe Hemophilia B: Two Year Data from a Phase 2b Trial Presenter:Annette von Drygalski, M.D., PharmD Session Name:801\. Gene Editing, Therapy and Transfer I Date:Monday, December 7, 2020 Presentation Time:2:45 p.m. ET (11:45 a.m. PT) Poster Presentations Title:AMT-060 Gene Therapy in Adults with Severe or Moderate-Severe Hemophilia B Confirm Stable FIX Expression and Durable Reductions in Bleeding and Factor IX Consumption for up to 5 Years Session Name:801\. Gene Editing, Therapy and Transfer: Poster III Date:Monday, December 7, 2020 Presentation Time:10:00 a.m. - 6:30 p.m. ET (7:00 a.m. - 3:30 p.m. PT) Title:A Single Administration of AAV5-hFIX in Newborn, Juvenile and Adult Mice Leads to Stable hFIX Expression up to 18 Months after Dosing Session Name:801\. Gene Editing, Therapy and Transfer: Poster II Date:Sunday, December 6, 2020 Presentation Time:10:00 a.m. - 6:30 p.m. ET (7:00 a.m. - 3:30 p.m. PT) Title:Examining the Hemophilia Disability Paradox Session Name:904\. Outcomes Research—Non-Malignant Conditions: Poster II Date:Sunday, December 6, 2020 Presentation Time:10:00 a.m. - 6:30 p.m. ET (7:00 a.m. - 3:30 p.m. PT) The conference abstracts are available and can be accessed through this link: ASH abstracts.About uniQure uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases. www.uniQure.comuniQure Forward-Looking StatementsThis press release contains forward-looking statements. All statements other than statements of historical fact are forward-looking statements, which are often indicated by terms such as "anticipate," "believe," "could," "estimate," "expect," "goal," "intend," "look forward to", "may," "plan," "potential," "predict," "project," "should," "will," "would" and similar expressions. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. These forward-looking statements include, but are not limited to, whether we will present long-term follow-up data from our hemophilia B gene therapy studies, including two years of follow-up on the Phase IIb clinical trial of etranacogene dezaparvovec (AMT-061) and up to five years of follow-up from the Phase I/II clinical trial of AMT-060, and whether we will announce top-line data from the pivotal HOPE-B study of etranacogene dezaparvovec before the end of this year. Our actual results could differ materially from those anticipated in these forward-looking statements for many reasons, including, without limitation, risks associated with our and our collaborators’ clinical development activities, clinical results, collaboration arrangements, corporate reorganizations and strategic shifts, regulatory oversight, product commercialization and intellectual property claims, as well as the risks, uncertainties and other factors described under the heading "Risk Factors" in uniQure’s Quarterly Report on Form 10-Q filed on October 27, 2020. Given these risks, uncertainties and other factors, you should not place undue reliance on these forward-looking statements, and we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.uniQure Contacts: FOR INVESTORS: FOR MEDIA: Maria E. CantorChiara RussoTom Malone Direct: 339-970-7536Direct: 617-306-9137Direct: 339-970-7558 Mobile: 617-680-9452Mobile: 617-306-9137Mobile:339-223-8541 m.cantor@uniQure.comc.russo@uniQure.comt.malone@uniQure.com
UK now has access to seven million shots of two-dose vaccine — enough to inoculate 3.5 million Britons
More than 158,000 jobs in UK retail have been lost so far this year, new data revealed on Monday as the future of Sir Philip Green's Arcadia Group looked uncertain. Staff at Topshop and Burton owner Arcadia Group were today waiting to hear if a rescue deal could be agreed for the company. The firm, which employs around 13000 people, is understood to be preparing to appoint administrators from Deloitte as soon as today, after talks with lenders about a £30 million loan ended without success.
The best time to see today’s full moon will be as it rises shortly after sunset
DHgate is organizing China (Suzhou) Online Trade Fair from November 26th, 2020 to February 25th, 2021.
It's never too early to start browsingFrom Country Living
Dublin, Nov. 30, 2020 (GLOBE NEWSWIRE) -- The "The Global Paper Tissues Market and the Impact of COVID-19 in the Medium Term" report has been added to ResearchAndMarkets.com's offering. This report presents a strategic analysis of the global paper tissues market and a forecast for its development in the medium term, taking into account the impact of COVID-19 on it. It provides a comprehensive overview of the market volume and value, dynamics, segmentation, characteristics, main players, prices, international trade, trends and insights, growth and demand drivers, challenges, etc. This is the most detailed (COVID-19 updated) and comprehensive report about the global paper tissues market, covering all global regions and 151 single countries. The report presents information on each indicator for each of the 151 countries covered, offering unmatched value, accuracy and expert insights. The purpose of the report is to describe the state of the global paper tissues market and to present real and expert-verified information about the volumes, values, dynamics, segmentation and characteristics of consumption, prices, imports, and exports. The report also presents a forecast for the market development in the medium term and the impact COVID-19 has and will have on it. In addition, the report presents an elaborate analysis of the main market participants, industry trends and insights, growth and demand drivers and challenges and all other factors, influencing the market development. Questions This Report Answers * Market volume, value and dynamics for the last five years * Market segmentation (by region and each covered country; by product groups, etc.) for the last five years * Analysis of the factors, influencing the market development (market trends and insights, drivers and challenges) and the impact COVID-19 has and will have on the market in both the short and the medium term * Value chain analysis and structure of price formation * Analysis of retail price levels and their dynamics for the last five years (broken down by region and each covered country) * Analysis of the major international trade flows * Volume, value, dynamics, segmentation (by region and each covered country) and analysis of imports for the last five years * Volume, value, dynamics, segmentation (by region and each covered country) and analysis of exports for the last five years * Volume and dynamics of the average import and export prices for the last five years (broken down by region and each covered country) * Volume, value, dynamics, segmentation and analysis of per capita consumption for the last five years (broken down by region and each covered country) * Forecast for market development in the medium term (volume, value and segmentation by region and each covered country) * Characteristics of the main players on the market * Analysis of the competitive landscape * Five Forces analysis * Analysis and forecast for the global economy and demographics.This research report has been prepared using the the publisher's methodology, including a blend of qualitative and quantitative data. The information comes from official sources and insights from market experts (representatives of the main market participants), gathered by semi-structured interviews. For this particular report, more than 50 market expert interviews have been conducted with experts from the leading market companies (producers, distributors, retailers, suppliers, etc.). The full list of interviewed experts and a detailed methodology are available upon request. This is the most valuable, detailed (COVID-19 updated) and comprehensive report about the global paper tissues market currently available, covering all global regions and 151 single countries! The publisher also offers similar reports, covering every global country and region separately and offer special terms for bundle purchases. So, if you are interested in the global paper tissues market, this research report will provide you with reliable, expert-verified and real market data you can safely and confidently base your decisions on. In a quick and hassle-free way, it will provide you with a strategic analysis of the market, its recent and future development. In addition, this solution will save you time and money while presenting you all the necessary information, empowering you to make informed commercial decisions and move your business forward! This report is the most in-depth publicly available business analysis that exists on this particular market. The report will be dispatched in up to 5 working days after order confirmation. Key Topics Covered: 1\. Introduction 2\. Research Methodology 3\. Executive Summary 4\. Product Description 5\. State of the Global Demographics and Economy 5.1. Characteristics of the Global Demographics in 2015-2019 5.2. Characteristics of the Global Economy in 2015-2019 5.3. Forecast for the Development of the Global Economy in the Short Term 6\. Overview, Segmentation and Analysis of the Global Paper Tissues Market 6.1. Volume, Value and Dynamics of the Global Paper Tissues Market in 2015-2019 6.2. Segmentation of the Global Paper Tissues Market in 2015-2019 by Main Regions 6.3. Segmentation of the Global Paper Tissues Market in 2015-2019 by Countries 6.4. Trends and Insights of the Global Paper Tissues Market 6.5. Profiles of the Main Players on the Global Paper Tissues Market 6.6. Five Forces Analysis 6.7. Competitive Landscape on the Global Paper Tissues Market 6.8. Drivers and Challenges That Will Affect the Future Development of the Global Paper Tissues Market 7\. Characteristics and Analysis of the Global Prices of Paper Tissues in 2015-2019 7.1. Value Chain Analysis 7.2. Structure of Price Formation 7.3. Segmentation of the Average Retail Prices of Paper Tissues Globally in 2015-2019 by Main Regions 7.4. Segmentation of the Average Retail Prices of Paper Tissues Globally in 2015-2019 by Countries 8\. Global Foreign Trade Operations of Paper Tissues 8.1. Global Foreign Trade Operations of Paper Tissues in 2015-2019 9\. Overview, Segmentation and Analysis of the Global Imports of Paper Tissues 9.1. Volume, Value and Dynamics of the Global Imports of Paper Tissues in 2015-2019 9.2. Segmentation of the Global Imports of Paper Tissues by Importing Regions in 2015-2019 9.3. Segmentation of the Global Imports of Paper Tissues by Importing Countries in 2015-2019 9.4. Segmentation of the Average Import Prices of Paper Tissues by Importing Countries in 2015-2019 10\. Overview, Segmentation and Analysis of the Global Exports of Paper Tissues 10.1. Volume, Value and Dynamics of the Global Exports of Paper Tissues in 2015-2019 10.2. Segmentation of the Global Exports of Paper Tissues by Exporting Regions in 2015-2019 10.3. Segmentation of the Global Exports of Paper Tissues by Exporting Countries in 2015-2019 10.4. Segmentation of the Average Export Prices of Paper Tissues by Exporting Countries in 2015-2019 11\. Characteristics and Segmentation of the Global Consumption of Paper Tissues per Capita 11.1. Segmentation of the Global Paper Tissues Consumption per Capita by Main Regions in 2015-2019 11.2. Segmentation of the Global Paper Tissues Consumption per Capita by Countries in 2015-2019 12\. Forecast for Development of the Global Paper Tissues Market in 2020-2025 12.1. Forecast for Development of the Global Paper Tissues Market in 2020-2025 in Three Possible Scenarios 12.2. Forecast for Development of the Global Paper Tissues Market, Broken down by Main Regions in 2020-2025 12.3. Forecast for Development of the Global Paper Tissues Market, Broken down by Countries in 2020-2025 Companies Mentioned * Kimberly-Clark * SCA * Georgia-Pacific * Procter & Gamble * Hengan International * Vinda * WEPA * Metsa Group * Kruger * C & S * 3M * SC Johnson * Unilever * Beiersdorf * Johnson & JohnsonFor more information about this report visit https://www.researchandmarkets.com/r/m15gc4Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The crash happened 11 billion years ago, when the Milky Way was four times smaller than it is now
Moderna Inc. said it would ask U.S. and European regulators Monday to allow emergency use of its COVID-19 vaccine as new study results confirm the shots offer strong protection — ramping up the race to begin limited vaccinations as the coronavirus rampage worsens. Multiple vaccine candidates must succeed for the world to stamp out the pandemic, which has been on the upswing in the U.S. and Europe. U.S. hospitals have been stretched to the limit as the nation has seen more than 160,000 new cases per day and more than 1,400 daily deaths.